A patient with perforated appendicitis developed progressive vasodilatory shock which was complicated by perioperative acute myocardial infarction. Cardiovascular support included dopamine infusion, and later, intra-aortic balloon counterpulsation balloon pump and noradrenaline and dobutamine infusion. Vasopressin was introduced as a final attempt to reverse the refractory shock and was associated with recovery. The experience with this case suggests that vasopressin may be a valuable adjunct to the treatment of catecholamine-resistant vasodilatory shock.
Vasopressin is an important posterior pituitary hormone that regulates the blood pressure and volume mainly through its antidiuretic effect. It may also play a role in circulatory control in shock 1 . It is used to treat diabetes insipidus. In doses of 0.1 to 0.4 units/min, it is used as a temporizing measure to control bleeding gastro-oesophageal varices 2 . We report a case of its use in perioperative septic and cardiogenic shock which failed to respond to noradrenaline infusion.
CASE HISTORY
A 70-year-old Chinese man presented to the hospital with an acute abdomen. There was no other past medical history of note. He had been a smoker for the past fifty years and he weighed 70 kg on admission. Clinically he was in septic shock, with a temperature of 38.9°C and blood pressure of 76/40 mmHg. Fluid resuscitation and dopamine infusion at 7 µg/kg/min brought the blood pressure to 120/50 mmHg. Mild renal impairment was present with a serum creatinine of 143 mmol/l on admission. The preoperative ECG was normal. At emergency laparotomy, perforated appendicitis with peritonitis was found. In view of the patient's perioperative septic shock state, he was transferred to the surgical intensive care unit for ventilatory support and further management. Inotropic support was switched to noradrenaline and dobutamine infusion, titrating the effect to a mean arterial pressure above 80 mmHg and urine output above 1 ml/kg/h.
In view of persistent haemodynamic lability, a pulmonary artery flotation catheter was inserted to guide management on the second postoperative day. Haemodynamic data were consistent with vasodilatory shock (Table 1) . His subsequent postoperative course was complicated by pulmonary oedema secondary to acute antero-septal myocardial infarction. Serial cardiac enzymes are depicted in Table 2 ; serial ECGs in Figures 1 and 2.
Transthoracic echocardiography showed severe hypokinesia of the antero-septal area with left ventricular ejection fraction of 10 to 20%. As the low cardiac output state did not improve with dobutamine, an intra-aortic counterpulsation balloon pump was inserted. However, the systemic vascular resistance continued to deteriorate and hypotension was refractory to noradrenaline at an infusion rate of 2.8 µg/kg/min.
On the third postoperative day, vasopressin at 0.02 IU/min was added to the regimen. The effect on the systemic vascular resistance was evident within three hours. At 12 hours, the systemic vascular resistance had increased to 1105 dyn.s.cm -5 and the mean arterial pressure was 80 mmHg ( Table 1 ). The noradrenaline was tailed down and his urine output was maintained above 100 ml/h. The peritoneal swab cultured positive for E. coli which was sensitive to piperacillin/tazobactam. He had been treated with this combination of antibiotics empirically and he responded well. The intra-aortic balloon pulsation was removed on postoperative day 6; vasopressin, noradrenaline and dobutamine were weaned on postoperative days 8, 9 and 11 respectively. He was extubated on day 20 and discharged from ICU on day 27. He survived to hospital discharge a month later. 
DISCUSSION
Vasopressin is a naturally occurring nona-peptide and exists in the 8-arginine form in most mammals except swine. It is synthesized in the supraoptic and paraventricular nuclei of the hypothalamus and transported to the posterior pituitary. It is released into the circulation in response to an increase in plasma osmolality and in response to hypotension or hypovolaemia. Vasopressin plays a key role in the regulation of body fluid balance through its antidiuretic action. This is mediated by V2-receptors in the renal collecting duct, which increases the number of water channels and hence facilitate water reabsorption.
Its potent vasoconstrictor action on the other hand is mediated by vascular V1A-receptors which affect vessels of the skin, skeletal muscle, fat, spleen, thyroid, heart, gut and brain 3, 4 .
It appears that vasopressin is a more potent vasoconstrictor than angiotensin II or noradrenaline, and is capable of increasing systemic vascular resistance in doses less than those required to produce maximum urine concentration 1 . However, vasopressin infusions have been shown to produce negligible pressor effects in hypotensive but otherwise healthy individuals 5 . This may be due to its action via V1 receptors to reset the cardiac baroreflex to a lower pressure 3, 6 . In previous animal studies, baroreceptor denervation had been shown to enhance pressor sensitivity to vasopressin 7, 8 . This sensitivity was also demonstrated in patients with autonomic failure such as idiopathic orthostatic hypotension 9 , diabetic orthostatic hypotension 10 , haemodialysis 11 and septic shock 12, 13 .
Argenziano et al 14 found that in recipients of a left ventricular assist device who developed vasodilatory shock, the majority had low vasopressin levels. The severity of shock and magnitude of response to vasopressin was related to the degree of its deficiency. Landry et al 15 also found that patients with septic shock had significantly lower levels of vasopressin than patients with cardiogenic shock. The inappropriately low levels may be due to decreased secretion. It is unlikely that hormonal clearance is increased as infusion of exogenous vasopressin produced an appropriate increase in plasma concentration 15 . The decreased secretion rate may be due to the impaired baroreflex in autonomic failure or depletion of neurohypophyseal stores secondary to excessive secretion in the early stage of septic shock. Endotoxin is a very potent secretagogue and an enormous increase in plasma vasopressin followed by rapid decline has been observed in animal models of acute septic shock 16, 17 .
In patients with vasodilatory shock who were not vasopressin deficient, administration of vasopressin can still bring about a substantial increase in systemic vascular resistance 14 . Vasopressin may partially reverse the adrenergic hyporesponsiveness associated with sepsis and circulatory bypass by inhibiting cytokine-induced nitric oxide production in vascular smooth muscle 18 . Vasopressin acting on V1 receptors could work synergistically with noradrenaline to bring about an enhanced release of calcium in the myoplasm 19 .
In the few case reports and series of its use in the treatment of vasodilatory shock, vasopressin has been found to be effective as a pressor 12, 18, 20 . Complications such as myocardial or mesenteric ischaemia have not been reported.
Our patient presented a great therapeutic challenge in the form of perioperative acute myocardial infarction in addition to septic shock. The septic shock was associated with a low systemic vascular resistance which responded initially to dopamine infusion. The haemodynamic aim was to maximize cardiac output and to maintain tissue perfusion pressure with a combination of noradrenaline and lowdose dobutamine. Martin et al 21 reported that this combination significantly improved left ventricular performance of septic shock patients. However, as the shock state progressed, withdrawal of dobutamine and infusion of noradrenaline up to 2.8 µg/kg/min failed to reverse the hypotension. A persistently low systemic vascular resistance in this situation is known to be associated with a high mortality rate 22 . When acute myocardial infarction occurred, the cardiac output deteriorated significantly. Intra-aortic balloon pulsation was used in an attempt to improve myocardial function by augmenting coronary perfusion during ventricular diastole and reducing afterload during ventricular systole. However, in the presence of a rapid heart rate and low systemic vascular resistance, the cardiac output improved only marginally. Interpretation of haemodynamic parameters was confounded by the inconsistent effect of intra-aortic balloon pulsation on arterial blood pressures.
Intuitively, vasopressin may increase ventricular afterload, and hence myocardial work and oxygen demand. However, by increasing the mean arterial pressure and reflex slowing of tachycardia, the increase in myocardial work may be more than compensated by the increase in coronary perfusion. We postulate that the dose of vasopressin employed in our case restored tissue perfusion pressures without excessive vasoconstriction to the regional circulation. Clinically we did not detect any evidence of coronary, renal or mesenteric ischaemia throughout the period of infusion. In this complicated case scenario, it is not possible to ascertain the relative contribution of each therapeutic component to the overall cardiovascular improvement. However, the haemodynamic data and clinical experience in this case suggest that vasopressin was an important adjunct in the reversal of catecholamine-resistant vasodilatory shock.
To date, there is limited published data on the effect of vasopressin on regional circulation in human septic shock. There remain concerns about the potential deleterious effect of vasopressin especially on the coronary and mesenteric vascular tone. Until more data are available on these issues, it may be prudent to use vasopressin only after familiar inopressors fail to reverse hypotension in vasodilatory shock.
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